Botryoid-Type Embryonal Rhabdomyosarcoma

general

A histologic subtype of embryonal rhabdomyosarcoma that arises under the morphologic surface of body orifices such as the vagina, bladder, nasopharynx, and biliary tract.

Centers

111

Active Trials

—

Cancer Funding

Specific Cancer Types(1)

Name	Centers	Active Trials
Vaginal Botryoid-Type Embryonal Rhabdomyosarcoma	—	—

Top Centers for Botryoid-Type Embryonal Rhabdomyosarcoma(61)

Ranked by research excellence score (trials · grants · publications). Methodology →

#	Center	Research Tier	Active Trials	Cancer Funding	Score
1	Memorial Sloan Kettering Cancer CenterNew York, NY NCI Comprehensive Active Research Program	Active Research Program	2	—	54.9
2	Dana-Farber Cancer InstituteBoston, MA NCI Comprehensive Active Research Program	Active Research Program	2	—	54.9
3	Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins UniversityBaltimore, MD NCI Comprehensive Active Research Program	Active Research Program	2	—	54.9
4	Stanford Cancer InstitutePalo Alto, CA NCI Comprehensive Active Research Program	Active Research Program	2	—	54.9
5	Mayo Clinic Comprehensive Cancer CenterRochester, MN NCI Comprehensive Active Research Program	Active Research Program	2	—	54.9
6	Yale Cancer Center Yale School of MedicineNew Haven, CT NCI Comprehensive Active Research Program	Active Research Program	2	—	54.9
7	Vanderbilt-Ingram Cancer CenterNashville, TN NCI Comprehensive Active Research Program	Active Research Program	2	—	54.9
8	Herbert Irving Comprehensive Cancer CenterNew York, NY NCI Comprehensive Active Research Program	Active Research Program	2	—	54.9
9	Dan L Duncan Comprehensive Cancer Center at Baylor College of MedicineHouston, TX NCI Comprehensive Active Research Program	Active Research Program	2	—	54.9
10	The University of Texas MD Anderson Cancer CenterHouston, TX NCI Comprehensive Active Research Program	Active Research Program	2	—	54.9
11	The University of Chicago Medicine Comprehensive Cancer CenterChicago, IL NCI Comprehensive Active Research Program	Active Research Program	2	—	54.9
12	Simmons Comprehensive Cancer Center UT Southwestern Medical CenterDallas, TX NCI Comprehensive Active Research Program	Active Research Program	2	—	54.9
13	The Ohio State University Comprehensive Cancer Center - James Cancer Hospital & Solove Research InstituteColumbus, OH NCI Comprehensive Active Research Program	Active Research Program	2	—	54.9
14	Masonic Cancer CenterMinneapolis, MN NCI Comprehensive Active Research Program	Active Research Program	2	—	54.9
15	University of Wisconsin Carbone Cancer CenterMadison, WI NCI Comprehensive Active Research Program	Active Research Program	2	—	54.9
16	City of Hope Comprehensive Cancer CenterDuarte, CA NCI Comprehensive Active Research Program	Active Research Program	2	—	54.9
17	University of Colorado Cancer CenterAurora, CO NCI Comprehensive Active Research Program	Active Research Program	2	—	54.9
18	UF Health Cancer InstituteGainesville, FL NCI Clinical Active Research Program	Active Research Program	2	—	54.9
19	Montefiore Einstein Comprehensive Cancer CenterBronx, NY NCI Comprehensive Active Research Program	Active Research Program	2	—	54.9
20	Roswell Park Comprehensive Cancer CenterBuffalo, NY NCI Comprehensive Active Research Program	Active Research Program	2	—	54.9
21	University of Virginia Cancer CenterCharlottesville, VA NCI Comprehensive Active Research Program	Active Research Program	2	—	54.9
22	Sylvester Comprehensive Cancer CenterMiami, FL NCI Clinical Active Research Program	Active Research Program	2	—	54.9
23	The University of Arizona Cancer CenterTucson, AZ NCI Comprehensive Active Research Program	Active Research Program	2	—	54.9
24	Medical College of Wisconsin Cancer CenterMilwaukee, WI Active Research Program	Active Research Program	2	—	54.9
25	VCU Massey Comprehensive Cancer CenterRichmond, VA NCI Comprehensive Active Research Program	Active Research Program	2	—	54.9
26	UMass Memorial Health Cancer CenterWorcester, MA Active Research Program	Active Research Program	2	—	54.9
27	Cleveland Clinic Cancer CenterCleveland, OH Active Research Program	Active Research Program	2	—	54.9
28	Holden Comprehensive Cancer CenterIowa City, IA NCI Comprehensive Active Research Program	Active Research Program	2	—	54.9
29	Fred & Pamela Buffett Cancer CenterOmaha, NE NCI Clinical Active Research Program	Active Research Program	2	—	54.9
30	Sidney Kimmel Comprehensive Cancer Center at JeffersonPhiladelphia, PA NCI Comprehensive Active Research Program	Active Research Program	2	—	54.9
31	Rutgers Cancer InstituteNew Brunswick, NJ NCI Comprehensive Active Research Program	Active Research Program	2	—	54.9
32	University of Illinois Cancer CenterChicago, IL Active Research Program	Active Research Program	2	—	54.9
33	University of Hawai‘i Cancer CenterHonolulu, HI NCI Clinical Active Research Program	Active Research Program	2	—	54.9
34	UAMS Winthrop P. Rockefeller Cancer InstituteLittle Rock, AR Active Research Program	Active Research Program	2	—	54.9
35	Boston University Cancer CenterBoston, MA Active Research Program	Active Research Program	2	—	54.9
36	Houston Methodist Dr. Mary and Ron Neal Cancer CenterHouston, TX Active Research Program	Active Research Program	2	—	54.9
37	Cancer Center at IllinoisUrbana, IL Active Research Program	Active Research Program	2	—	54.9
38	Stony Brook Cancer CenterStony Brook, NY Active Research Program	Active Research Program	2	—	54.9
39	Penn State Cancer InstituteHershey, PA Active Research Program	Active Research Program	2	—	54.9
40	University of Cincinnati Cancer CenterCincinnati, OH Active Research Program	Active Research Program	2	—	54.9
41	Livestrong Cancer InstitutesAustin, TX Active Research Program	Active Research Program	2	—	54.9
42	Mayo Clinic Comprehensive Cancer Center, FloridaJacksonville, FL Active Research Program	Active Research Program	2	—	54.9
43	Mayo Clinic Comprehensive Cancer Center, ArizonaScottsdale, AZ Active Research Program	Active Research Program	2	—	54.9
44	Georgia Cancer Center, Augusta UniversityAugusta, GA Active Research Program	Active Research Program	2	—	54.9
45	The University of Vermont Cancer CenterBurlington, VT Active Research Program	Active Research Program	2	—	54.9
46	University of Puerto Rico Comprehensive Cancer CenterSan Juan, PR Active Research Program	Active Research Program	2	—	54.9
47	Upstate Cancer CenterSyracuse, NY Active Research Program	Active Research Program	2	—	54.9
48	Loma Linda University Cancer CenterLoma Linda, CA Active Research Program	Active Research Program	2	—	54.9
49	Tampa General Hospital Cancer InstituteTampa, FL Active Research Program	Active Research Program	2	—	54.9
50	Louisiana Cancer Research CenterNew Orleans, LA Active Research Program	Active Research Program	2	—	54.9
51	University of Michigan Rogel Cancer CenterAnn Arbor, MI NCI Comprehensive Contributing Research Center	Contributing Research Center	1	—	32.4
52	Siteman Cancer CenterSt. Louis, MO NCI Comprehensive Contributing Research Center	Contributing Research Center	1	—	32.4
53	UNC Lineberger Comprehensive Cancer CenterChapel Hill, NC NCI Comprehensive Contributing Research Center	Contributing Research Center	1	—	32.4
54	UCLA Jonsson Comprehensive Cancer CenterLos Angeles, CA NCI Comprehensive Contributing Research Center	Contributing Research Center	1	—	32.4
55	Duke Cancer InstituteDurham, NC NCI Comprehensive Contributing Research Center	Contributing Research Center	1	—	32.4
56	Laura and Isaac Perlmutter Cancer Center at NYU Langone HealthNew York, NY NCI Comprehensive Contributing Research Center	Contributing Research Center	1	—	32.4
57	Cedars-Sinai CancerLos Angeles, CA Contributing Research Center	Contributing Research Center	1	—	32.4
58	Dartmouth Cancer CenterLebanon, NH NCI Comprehensive Contributing Research Center	Contributing Research Center	1	—	32.4
59	Karmanos Cancer InstituteDetroit, MI NCI Comprehensive Contributing Research Center	Contributing Research Center	1	—	32.4
60	Princess Margaret Cancer CentreToronto, ON Contributing Research Center	Contributing Research Center	1	—	32.4
61	BC CancerVancouver, BC Contributing Research Center	Contributing Research Center	1	—	32.4

Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →